RESUMEN

We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox) nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES)-Gantrez® AN 119 Dox NPs of average size 220 nm with PDI < 0.62 and ∼20% Dox loading were prepared by modified nanoprecipitation. ASGPR ligands, pullulan (Pul), arabinogalactan (AGn), and the combination (Pul-AGn), were anchored by adsorption. Ligand anchoring enabled high liver uptake with a remarkable hepatocyte:nonparenchymal cell ratio of 85:15. Furthermore, Pul-AGn NPs exhibited an additive effect implying incredibly high hepatocyte accumulation. Galactose-mediated competitive inhibition confirmed ASGPR-mediated uptake of ligand-anchored NPs in HepG2 cell lines. Subacute toxicity in rats confirmed the safety of the NP groups. However, histopathological evaluation suggested mild renal toxicity of AGn. Pul NPs revealed sustained reduction in tumor volume in PLC/PRF/5 liver tumor-bearing Nod/Scid mice up to 46 days. Extensive tumor necrosis, reduced collagen content, reduction in the HCC biomarker serum α-fetoprotein (p < 0.05), a mitotic index of 1.135 (day 46), and tumor treated/tumor control (T/C) values of <0.42 signified superior efficacy of Pul NPs. Furthermore, weight gain in the NP groups, and no histopathological alterations indicated that they were well tolerated by the mice. The high efficacy coupled with greater safety portrayed Pul Dox NPs as a promising nanocarrier for improved therapy of HCC.

Asunto(s)

Antibióticos Antineoplásicos/administración & dosificación , Receptor de Asialoglicoproteína/metabolismo , Carcinoma Hepatocelular/tratamiento farmacológico , Doxorrubicina/administración & dosificación , Portadores de Fármacos , Glucanos/metabolismo , Neoplasias Hepáticas/tratamiento farmacológico , Nanopartículas , Poliésteres/química , Animales , Antibióticos Antineoplásicos/química , Antibióticos Antineoplásicos/metabolismo , Antibióticos Antineoplásicos/toxicidad , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patología , Colágeno/metabolismo , Doxorrubicina/química , Doxorrubicina/metabolismo , Doxorrubicina/toxicidad , Composición de Medicamentos , Femenino , Galactanos/química , Galactanos/metabolismo , Glucanos/química , Glucanos/toxicidad , Células Hep G2 , Humanos , Ligandos , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patología , Ratones Endogámicos NOD , Ratones SCID , Mitosis/efectos de los fármacos , Índice Mitótico , Nanomedicina , Necrosis , Poliésteres/toxicidad , Ratas Sprague-Dawley , Tecnología Farmacéutica/métodos , Factores de Tiempo , Distribución Tisular , Pruebas de Toxicidad Subaguda , Carga Tumoral/efectos de los fármacos , Ensayos Antitumor por Modelo de Xenoinjerto , alfa-Fetoproteínas/metabolismo

RESUMEN

We report carbohydrate-anchored polyethylene sebacate (PES)-Gantrez® AN 119 Doxorubicin hydrochloride (Dox) nanoparticles (NPs) for enhanced anticancer efficacy. The carbohydrates Arabinogalactan (AGn), an adjuvant in anticancer chemotherapy and pullulan (Pul) reported to promote collagen synthesis, were selected as ligands. PES Dox NPs of an average size around 200 nm, greater than 20% w/w Dox loading and negative zeta potential were anchored with Pul, AGn, and Pul-AGn combination by simple incubation. Increase in particle size and zeta potential confirmed carbohydrate anchoring. FTIR confirmed ionic complexation of Dox and Gantrez® AN 119. DSC and XRD demonstrated amorphization of Dox. Higher Dox release in pH 5.5 as compared with pH 7.4 is beneficial for reduced systemic toxicity and enhanced drug release in tumors. Good in vitro serum stability and low hemolysis revealed suitability for intravenous administration. All NPs revealed circulation longevity in normal rats. Pul NPs revealed superior anticancer efficacy in vitro and an 11-fold enhancement in uptake in MCF-7 breast cancer cells. The greater efficacy in vivo is attributed to possible pullulan-mediated integrin receptor uptake and interaction with tumor collagen. Histopathology confirmed safety and suggested promise of Pul NPs in improved anticancer efficacy.

Asunto(s)

Antineoplásicos/química , Neoplasias de la Mama/tratamiento farmacológico , Carbohidratos/química , Doxorrubicina/química , Nanopartículas/química , Poliésteres/química , Animales , Antineoplásicos/farmacología , Línea Celular Tumoral , Doxorrubicina/farmacología , Portadores de Fármacos/química , Sistemas de Liberación de Medicamentos/métodos , Femenino , Galactanos/química , Glucanos/química , Humanos , Células MCF-7 , Maleatos/química , Tamaño de la Partícula , Polivinilos/química , Ratas , Ratas Sprague-Dawley

RESUMEN

The present study evaluates role of pullulan as hepatic targeting agent. Nanoparticles of silymarin (SIM) a hepatoprotective drug were prepared using polyethylene sebacate (PES) as biodegradable polymer and surface modified with pullulan. PES-SIM nanoparticles (PES-SIM NP) and PES-SIM nanoparticles surface modified with pullulan (PES-SIM-PUL) were prepared by nanoprecipitation. Nanoparticles were evaluated for hepatoprotective activity in a model of carbon-tetrachloride (CCl4) induced hepatotoxicity in rats. Pretreatment of rats with PES-SIM-NP and PES-SIM-PUL revealed reduced levels of SGOT, SGPT and ALKP compared to CCl4 treated group (p < 0.01) whereas levels of LPO and catalase were comparable to vehicle control suggesting enhanced hepatoprotection with nanoparticles. Histopathological evaluation of liver tissues also revealed better hepatoprotection with nanoparticles. Further significant decrease (p < 0.01) in levels of SGOT, SGPT and ALKP with difference PES-SIM-PUL than PES-SIM NP confirms the role of pullulan as hepatic targeting agent.

Asunto(s)

Hígado/efectos de los fármacos , Nanopartículas/química , Poliésteres/química , Sustancias Protectoras/química , Silimarina/química , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas , Femenino , Hígado/patología , Nanopartículas/administración & dosificación , Tamaño de la Partícula , Poliésteres/administración & dosificación , Poliésteres/farmacología , Sustancias Protectoras/administración & dosificación , Sustancias Protectoras/farmacología , Ratas , Ratas Sprague-Dawley , Silimarina/administración & dosificación , Silimarina/farmacología

RESUMEN

The present study reports the comparative pharmacokinetic evaluation and biodistribution of rifampicin (RIF) following oral administration of nanoparticles of a bioadhesive polymer, Gantrez and a hydrophobic polymer poly(ethylene sebacate) (PES). A specific objective of the study was to evaluate lung uptake of the nanoparticles following oral administration. Nanoparticles were obtained in the size range 350-450 nm with rifampicin loading of 12-14% w/w. Zeta potential confirmed colloidal stability. PES nanoparticles revealed high macrophage uptake compared to Gantrez nanoparticles, and direct correlation was observed between hydrophobicity (contact angle) and macrophage uptake (r2 -0.940). Enhanced RIF uptake with folic acid anchoring suggested folate receptor mediated uptake. RIF nanoparticles exhibited significantly higher Cmax and AUC, delayed Tmax and sustained release compared to plain RIF. More importantly the plasma concentration of RIF with the nanoparticles was significantly greater than the MIC of RIF (0.25 microng/mL) over 24 h. While gamma scintigraphy revealed higher lung accumulation of nanoparticles, the concentration with Gantrez nanoparticles was significantly higher. HPLC evaluation of lung concentration correlated with scintigraphy data. The significantly higher bioavailability and lung accumulation with Gantrez nanoparticle over PES nanoparticles was attributed mucoadhesion and high affinity of Gantrez to the Peyer's patches. Our study suggests Gantrez nanoparticles as a promising carrier for enhancing lung accumulation of drugs.

Asunto(s)

Pulmón/metabolismo , Maleatos/química , Nanocápsulas/química , Poliésteres/química , Polivinilos/química , Rifampin/administración & dosificación , Rifampin/farmacocinética , Administración Oral , Animales , Antibióticos Antituberculosos/administración & dosificación , Antibióticos Antituberculosos/química , Antibióticos Antituberculosos/farmacocinética , Disponibilidad Biológica , Masculino , Tasa de Depuración Metabólica , Nanocápsulas/ultraestructura , Especificidad de Órganos , Ratas Wistar , Rifampin/química , Distribución Tisular

RESUMEN

The present study discloses the design of folate anchored Rifampicin-Poly methylvinylether maleic anhydride copolymer (Gantrez AN-119, Gantrez) nanoparticles (RFMGzFa) by ionic complexation. Folic acid was anchored to the preformed drug loaded nanoparticles. Folic acid was anchored in different concentration by simply varying the amount of folic acid added during preparation. RFMGzFa nanoparticles were prepared by emulsion solvent diffusion method. Gantrez AN-119 rapidly hydrolyzes in aqueous medium releasing carboxylic acid groups, to create an acidic environment. This facilitates protonation and subsequent ionic complexation of folic acid with the carboxylic groups, to enable anchoring. FTIR spectra confirmed this interaction. Infrared imaging revealed distribution of folic acid across the nanoparticle surface. Nanoparticles were obtained in the size range 350-450 nm with RFM loading of 12-14% w/w. Zeta potential confirmed colloidal stability. TEM/SEM revealed spherical morphology. RFMGzFa nanoparticles exhibited sustained release of RFM and folic acid. Folic acid showed sustained release upto 12 h, which was ion exchange mediated. A 480% enhancement in RFM uptake with RFMGzFa nanoparticles compared to 300% with RFMGz nanoparticles in-vitro, in human macrophage cell line U-937, suggested the role of folic acid in folate receptor mediated uptake. Ionic complexation represents a simple non-covalent approach for anchoring folic acid on polymeric nanoparticles of Gantrez.

Asunto(s)

Antibióticos Antituberculosos/administración & dosificación , Fármacos Dermatológicos/administración & dosificación , Ácido Fólico/química , Sustancias Macromoleculares/síntesis química , Maleatos/administración & dosificación , Nanopartículas/química , Polivinilos/administración & dosificación , Rifampin/administración & dosificación , Antibióticos Antituberculosos/química , Antibióticos Antituberculosos/farmacocinética , Supervivencia Celular/efectos de los fármacos , Fármacos Dermatológicos/química , Fármacos Dermatológicos/farmacocinética , Sistemas de Liberación de Medicamentos , Diseño de Fármacos , Humanos , Enlace de Hidrógeno , Iones/química , Sustancias Macromoleculares/química , Maleatos/química , Maleatos/farmacocinética , Modelos Biológicos , Polivinilos/química , Polivinilos/farmacocinética , Rifampin/química , Rifampin/farmacocinética , Células U937

RESUMEN

Nucleic acids show immense potential to treat cancer, acquired immune deficiency syndrome, neurological diseases and other incurable human diseases. Upon systemic administration, they encounter a series of barriers and hence barely reach the site of action, the cell. Intracellular delivery of nucleic acids is facilitated by nanovectors, both viral and non-viral. A major advantage of non-viral vectors over viral vectors is safety. Nanovectors evaluated specifically for nucleic acid delivery include polyplexes, lipoplexes and other cationic carrier-based vectors. However, more recently there is an increased interest in inorganic nanovectors for nucleic acid delivery. Nevertheless, there is no comprehensive review on the subject. The present review would cover in detail specific properties and types of inorganic nanovectors, their preparation techniques and various biomedical applications as therapeutics, diagnostics and theranostics. Future prospects are also suggested.